Scientists say a new pill could radically change the way asthma patients are treated in future.

More than one person a week dies from Asthma in Ireland with nearly half a million people diagnosed with the disease here.

This new drug called Fevipiprant has proven successful in reducing the risk of an attack.

Professor Chris Brightling has been involved in the trial at the University of Leicester in the UK: